Presentation is loading. Please wait.

Presentation is loading. Please wait.

CANOVA South Africa 17 November 2005 Presented By: Dr M Mojapelo.

Similar presentations


Presentation on theme: "CANOVA South Africa 17 November 2005 Presented By: Dr M Mojapelo."— Presentation transcript:

1 CANOVA South Africa 17 November 2005 Presented By: Dr M Mojapelo

2 Dr Maggie Mojapelo Medical doctor Founder of Clinics of Hope
Has been involved in HIV/AIDS integrated management/wellness for the past 15 years Conducted a prospective study on Canova in SA

3 INTRODUCTION “Canova is a powerful immune modulator and a complementary medicine which does not present toxicity or known side effects to patients ”

4

5 IMMUNE SYSTEM - CELL INTERACTIONS
Phagocytosis Antigen presenting CD4 Resting macrophage CD4 Activated macrophage Macrophage B cell CD8 and NK

6 ? How Canova Works? CANOVA
Antigen presenting ? Phagocytosis Resting macrophage Activated macrophage Molecules are produced to all the immune system TNF, Nitric Oxid CANOVA

7 Conducted at Johannesburg from April 2005 to date
Clinical Study Conducted at Johannesburg from April 2005 to date 30 HIV positive patients Selection criteria Clinical Parameters Measured: Appetite Weight loss Opportunistic infections Energy levels Laboratory Parameters Measured: Viral Load CD4 count

8 Findings of the Clinical Study
All 30 patients tolerated Canova Viral Load % Decrease CD4 Count % Increase Weight % Increase Appetite % Increase Opportunistic infections % Decrease

9 Findings of the Clinical Study
Viral Load

10 Findings of the Clinical Study
CD4 Count

11 Findings of the Clinical Study
Weight

12 Findings of the Clinical Study
Appetite

13 Findings of the Clinical Research
Opportunistic infections Atypical Pneumonia - Skin Rashes - Neuropathies -Oral Thrush -Shingles After 3 months of treatment 80% of the OI’s showed marked improvement

14 Canova Benefits Canova is a type of medication that helps resuscitate a depressed immune system. Canova helps boost the immune system. Helps to fight all kinds of compromised immune systems related problems. Canova's effect of activating and enlarging the macrophages helps to decrease the incidence of opportunistic infections. Canova has no known side effects. Considerable improvement on the quality of life.

15 Canova is available in two forms:
Canova Product Canova is available in two forms: CANOVA INHALATION CANOVA DROPS

16 Conclusion Clinically Canova has shown massive impact on quality of life The importance of Canova is the absence of known side effects Canova can be used as a monotherapy or in combination with ARV’s Results show that Canova has a positive effect on Opportunistic infections


Download ppt "CANOVA South Africa 17 November 2005 Presented By: Dr M Mojapelo."

Similar presentations


Ads by Google